Skip to content
PICO Portalanswers from OpenAlex

Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD

PaperCitations, authors & open-access status

Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD is a paper indexed in PICO Portal from OpenAlex.

How many citations does Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD have?

PICO Portalcitation count

Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD has 60 citations in the OpenAlex counts PICO Portal stores.

When was Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD published?

PICO Portalyear

Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD has 2022 year in the PICO Portal index.

What is the open-access status of Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD?

PICO Portaloa status

Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD has green oa status in the PICO Portal index.

What is the DOI of Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD?

PICO Portaldoi

The DOI for Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD is on the source record.

What is the PMID of Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD?

PICO Portalpmid

The PMID for Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD is on the source record.

What is the OpenAlex record for Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD?

PICO Portalopenalex

The OpenAlex for Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial